They found that women with different timelines of diabetes onset (before, during, and after the menopausal transition) all exhibited lower β-cell function and insulin sensitivity during the period of menopausal transition compared with women who did not develop diabetes. The gene discussed is INS; the disease is diabetes mellitus.